null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-001665-33-FI

Enrollment

Registered

2012-04-18

Start date

2012-06-14

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis media acuta

Interventions

Trade Name: Amoxin comp 80/11,4mg/ml Product Name: Amoxicillin ratipharm Pharmaceutical Form: Powder for oral suspension INN or Proposed INN: AMOXICILLIN CAS Number: 26787-78-0 INN or Proposed INN: CL

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Otitis media with drainage from the ventilation tube in children between 1 to 5 years. Are the trial subjects under 18? yes Number of subjects for this age range: 90 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Otherwise sick children.

Design outcomes

Primary

Measure	Time frame
Main Objective: Comparison of different medical treatments for otitis media in ears with a ventilation tube.;Secondary Objective: ;Primary end point(s): Treatment for 6 days.;Timepoint(s) of evaluation of this end point: Between 6-8 days, in working days.	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026